Detalles de la búsqueda
1.
Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
Allergy Asthma Proc;
44(4): 275-282, 2023 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328263
2.
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
N Engl J Med;
376(12): 1131-1140, 2017 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28328347
3.
Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States.
Ann Allergy Asthma Immunol;
119(1): 59-64, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28668241
4.
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Ann Allergy Asthma Immunol;
117(5): 508-513, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27788880
5.
Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
J Emerg Med;
50(4): 567-80.e1, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26826769
6.
Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
Allergy Asthma Proc;
36(3): 218-24, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25803207
7.
Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema.
Transfusion;
54(10): 2566-73, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24805006
8.
C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Pediatr Allergy Immunol;
24(1): 54-60, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23173714
9.
Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
Ann Allergy Asthma Immunol;
111(3): 211-5, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23987198
10.
Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review.
Allergy Asthma Proc;
34(4): 312-327, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23710659
11.
Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedema.
J Allergy Clin Immunol;
139(6): 2005-2007.e1, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28025012
12.
C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
Allergy Asthma Proc;
33(5): 427-31, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23026185
13.
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Allergy Asthma Proc;
33(4): 354-61, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22856636
14.
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
N Engl J Med;
359(13): 1317-29, 2008 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-18815396
15.
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
N Engl J Med;
359(12): 1238-51, 2008 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18753638
16.
Telmisartan to prevent recurrent stroke and cardiovascular events.
N Engl J Med;
359(12): 1225-37, 2008 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18753639
17.
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Orphanet J Rare Dis;
16(1): 86, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588897
18.
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene.
Orphanet J Rare Dis;
15(1): 52, 2020 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066472
19.
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Orphanet J Rare Dis;
15(1): 289, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059692
20.
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks.
Allergy Asthma Clin Immunol;
15: 13, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30899278